Cumulus Neuroscience
The company provides the NeuLogiq platform, which combines digital assessments and neurophysiological data for longitudinal monitoring of brain functions. This system is designed for use in central nervous system (CNS) clinical trials to provide objective, real-world data for pharmaceutical researchers. The platform supports both in-clinic and at-home monitoring to track treatment effects and patient engagement.
Visit websiteBelfast, United Kingdom
Healthtech
Biotechnology
Pharmaceuticals
Neuroscience
Funding summary
- Total raised
- €10.7M
- Funding rounds
- 2
Investors in Cumulus Neuroscience
Investors on record for Cumulus Neuroscience. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Cumulus Neuroscience?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors